Cardiorespiratory Fitness and Incident Stroke Types: The FIT (Henry Ford ExercIse Testing) Project by Al Rifai, Mahmoud et al.
Henry Ford Health System 
Henry Ford Health System Scholarly Commons 
Cardiology Articles Cardiology/Cardiovascular Research 
7-1-2020 
Cardiorespiratory Fitness and Incident Stroke Types: The FIT 
(Henry Ford ExercIse Testing) Project 
Mahmoud Al Rifai 
Michael J. Blaha 
Amjad Ahmed 
Fatimah Almasoudi 
Michelle C. Johansen 
See next page for additional authors 
Follow this and additional works at: https://scholarlycommons.henryford.com/cardiology_articles 
Authors 
Mahmoud Al Rifai, Michael J. Blaha, Amjad Ahmed, Fatimah Almasoudi, Michelle C. Johansen, Waqas 
Qureshi, Sherif Sakr, Salim S. Virani, Clinton A. Brawner, Jonathan K. Ehrman, Steven J. Keteyian, and 
Mouaz H. Al-Mallah 
Cardiorespiratory Fitness and Incident Stroke
Types: The FIT (Henry Ford ExercIse Testing)
Project
Mahmoud Al Rifai, MD, MPH; Michael J. Blaha, MD, MPH; Amjad Ahmed, MBBS;
Fatimah Almasoudi, MS; Michelle C. Johansen, MD; Waqas Qureshi, MD, MS;
Sherif Sakr, PhD; Salim S. Virani, MD, PhD; Clinton A. Brawner, PhD;
Jonathan K. Ehrman, PhD; Steven J. Keteyian, PhD;
and Mouaz H. Al-Mallah, MD, MSc
Abstract
Objective: To study the association between cardiorespiratory fitness (CRF) and incident stroke types.
Patients and Methods: We studied a retrospective cohort of patients referred for treadmill stress
testing in the Henry Ford Health System (Henry Ford ExercIse Testing Project) without history of
stroke. CRF was expressed by metabolic equivalents of task (METs). Using appropriate International
Classification of Diseases, Ninth Revision codes, incident stroke was ascertained through linkage with
administrative claims files and classified as ischemic, hemorrhagic, and subarachnoid hemorrhage
(SAH). Multivariable-adjusted Cox proportional hazards models examined the association between
CRF and incident stroke.
Results: Among 67,550 patients, mean  SD age was 5413 years, 46% (n¼31,089) were women,
and 64% (n¼43,274) were white. After a median follow-up of 5.4 (interquartile range 2.7-8.5) years, a
total of 7512 incident strokes occurred (6320 ischemic, 2481 hemorrhagic, and 275 SAH). Overall,
there was a graded lower incidence of stroke with higher MET categories. Patients with METs of 12 or
more had lower risk of overall stroke [0.42 (95% CI, 0.36-0.49)], ischemic stroke [0.69 (95% CI,
0.58-0.82)], and hemorrhagic stroke [0.71 (95% CI, 0.52-0.95)].
Conclusion: In a large ethnically diverse cohort of patients referred for treadmill stress testing, CRF is
inversely associated with risk for ischemic and hemorrhagic stroke.
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S troke remains a leading cause oflong-term disability in the UnitedStates. The annual incidence rate of
stroke is 695,000 cases per year. Stroke
ranks number 5 among all causes of death,
with nearly 133,000 attributable deaths.1
Modifiable risk factors, including physical
activity, account for nearly 90% of the
population-attributable risk for stroke.2
Although physical activity is self-reported
and subject to measurement error,
cardiorespiratory fitness (CRF) testing is
an objective and reproducible marker of car-
diovascular health in the general adult popu-
lation.3-5
CRF refers to the ability of the heart and
lungs to deliver oxygenated blood to the
working muscles of the body to perform dy-
namic exercise. Importantly, it integrates the
upstream effects of physical activity, ge-
netics, risk factor, and disease burden across
an individual’s lifespan. CRF is typically
measured by measuring peak or maximal ox-
ygen uptake (VO2max, in mL/kg/min), which
represents the body’s maximal ability to
transport and use oxygen when performing
work. During this test, patients undergo a
maximal graded test on a treadmill or bicy-
cle. The exercise test becomes gradually
more difficult and VO2max is established
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when oxygen consumption reaches its peak
or levels off at the time that the patient
ends the test. An alternative way of assessing
CRF during a treadmill exercise stress test is
based on achieved speed and elevation,
whereby CRF is expressed in metabolic
equivalents of task (METs) using output
data from the Quinton treadmill controller.6
Lower CRF is associated with higher
risk for cardiovascular risk factors, atrial
fibrillation (AF), coronary heart disease,
all-cause mortality, and cardiovascular mor-
tality.7-11 Previous studies have also
demonstrated an inverse association be-
tween baseline and change in CRF with
risk for stroke. However, these studies
have included males only, lacked ethnic di-
versity, or exclusively assessed overall
stroke outcomes rather than stroke
types.12-16 We therefore evaluated the asso-
ciation between CRF and risk for incident
stroke in a sex-balanced and multiethnic
cohort with long-term follow-up for overall
stroke including stroke types (ischemic,
hemorrhagic, and subarachnoid hemor-
rhage [SAH]). We hypothesized that CRF
is inversely associated with stroke types in-
dependent of traditional risk factors.
PATIENTS AND METHODS
Study Design
We used data from the Henry Ford ExercIse
Testing (FIT) Project, a retrospective cohort
of patients who were referred for exercise
stress testing. The methods of the FIT Proj-
ect have been previously described.17,18
The FIT Project is a single-health-system
investigator-initiated study of 69,885 consec-
utive patients who underwent physician-
referred treadmill stress testing at Henry
Ford Health Systemeaffiliated hospitals and
ambulatory care centers in metropolitan
Detroit, Michigan, between January 1991
and May 2009. Patients younger than
18 years at the time of stress testing or those
who underwent pharmacologic stress
testing, modified Bruce, and other
non-Bruce protocol tests (w0.5%) were not
included in the study. The FIT Project was
approved by the Henry Ford Health System
Institutional Review Board.17 The data that
support the findings of this study are avail-
able from the corresponding author on
reasonable request.
Exclusion Criteria
Individuals with prior stroke at baseline
(n¼1340), missing CRF data (n¼938), or
lacking information for follow-up time for
incident stroke (n¼57) were excluded from
the present analysis.
Assessment of CRF
All patients underwent symptom-limited
maximal treadmill stress testing using a stan-
dard Bruce protocol.6 Following American
College of Cardiology/American Heart Asso-
ciation guidelines, stress testing was termi-
nated at the discretion of the supervising
clinician for potentially life-threatening rea-
sons, including abnormal hemodynamic
changes, arrhythmias, ischemic ST-segment
changes, symptoms such as chest pain or
shortness of breath limiting exercise, or if
the patient could no longer continue.19
CRF (expressed in METs) was assessed us-
ing output data from the Quinton treadmill
controller output data based on speed and
elevation achieved during stress testing.6
METs were categorized a priori into 4
groups: less than 6, 6 to 9, 10 to 11, and
12 or more. These categories were selected
because they best fit the distribution of the
FIT Project and were used in all prior publi-
cations. Additionally, prior studies have
demonstrated a graded association between
these MET categories and risk for cardiovas-
cular outcomes and all-cause
mortality.5,9,10,20
Follow-up and Ascertainment of Stroke
Incident stroke was ascertained by linkage
with claims files and classified using Interna-
tional Classification of Diseases, Ninth Revi-
sion (ICD-9) codes into ischemic stroke
(433.01, 433.11, 433.21, 433.31, 433.81,
433.91, 434, 434.01, 434.11, 434.91, 436,
437, and 438), hemorrhagic stroke (431
and 432), and SAH (430). Use of ICD-9
codes for stroke ascertainment was validated
in a prior report from the Atherosclerosis
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Risk in Communities Study,21 which showed
that the codes had 76% positive predictive
value and 68% sensitivity compared with
72% positive predictive value and 83% sensi-
tivity based on the Atherosclerosis Risk in
Communities adjudicated stroke diagnosis.
A diagnosis of incident stroke was
considered present if the appropriate ICD-9
code was identified in 3 or more follow-up
outpatient encounters. The requirement of
at least 3 follow-up encounters was chosen
a priori to increase the specificity of stroke
diagnosis. This was used in all outcomes in
the FIT Project. This was done to primarily
avoid misclassification of patients for
whom “rule out stroke” could have been
coded as incident stroke.
Patients who experienced more than 1
stroke type were censored after the occur-
rence of the first stroke. For example, if a pa-
tient had an ischemic stroke at time A and
another ischemic stroke at a later time B,
they were censored at both time A for over-
all stroke. However, in analyses of stroke
type, they were censored at times A and B.
This is why the sum of stroke types is
greater than the number of overall stroke
outcomes in this study. An incident non-
stroke outcome (such as coronary artery dis-
ease [CAD]) occurring before the
development of stroke did not result in
censoring. Patients were censored at the
time of death or at their last contact with
the Henry Ford Health System when
ongoing coverage with the health plan could
no longer be confirmed to minimize bias
from loss to follow-up.
Assessment of Covariates
Data Collection. A nurse and/or clinical ex-
ercise physiologist collected demographic in-
formation, indication for stress testing,
medical history, and medication use on the
day of the stress test. Other risk factors
were gathered by self-report at the time of
the test, then supplemented by a retrospec-
tive search of the electronic medical record
and administrative databases consisting of
medical records, laboratory values, and
claims files. A database-verified diagnosis
was considered present when the appro-
priate code was listed in at least 3 separate
encounters within the health system. Medi-
cation use was supplemented using phar-
macy claims data and classified into
common indications (eg, antihypertensive,
lipid or glucose lowering, and warfarin).
Covariate Definitions for Risk Factors of
Interest. Race/ethnicity was defined exclu-
sively by self-report. Obesity was self-
reported and/or assessed by the clinician or
defined based on height and weight data as
body mass index (calculated as the weight in
kilograms divided by the height in meters
squared) of 30 or more kg/m2. Current
smoking was defined as self-reported active
smoking at the time of stress testing. Indi-
cation for stress testing was obtained from
the stress test requisition form provided by
the referring physician and subsequently
categorized into common indications (eg,
chest pain, shortness of air, and evaluation
for possible ischemia; Supplemental Table 1,
available online at http://www.
mayoclinicproceedings.org). Diabetes melli-
tus was defined as a previous diagnosis of
diabetes, glucose-lowering medication use
including insulin, or a database-verified
diagnosis. Hypertension was defined as a
previous diagnosis of hypertension, antihy-
pertensive medication use, or a database-
verified diagnosis; measured blood pressure
at the time of the test was not used to di-
agnose hypertension. Dyslipidemia was
defined as previous diagnosis of any major
lipid abnormality, lipid-lowering medication
use, or a database-verified diagnosis. Family
history of CAD was defined as CAD in a
first-degree relative. Personal history of CAD
was defined as prior coronary angioplasty,
myocardial infarction, coronary artery
bypass surgery, or obstructive CAD on
angiography. Prior AF or flutter was defined
as prior clinical diagnosis of at least parox-
ysmal AF. Prior congestive heart failure
(CHF) was defined as prior clinical diagnosis
of systolic or diastolic heart failure.
Incident nonstroke outcomes (AF,
hypertension, diabetes, and CAD) were
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ascertained by linkage with claims files
from services delivered by the system-
affiliated group practice or reimbursed by
the system’s health plan. Linkage was per-
formed by use of the appropriate ICD-9
codes (427.31, 401.XX, 410.XX, and
250.XX for AF,10 hypertension,22 diabetes,9
and CAD,11 respectively) and/or Current
Procedural Terminology codes. Adjustment
for nonstroke outcomes is important
because preventive medications can be
initiated or intensified following their
occurrence, which may affect risk for sub-
sequent stroke.
TABLE 1. Baseline Characteristics of Study Cohort By Cardiorespiratory Fitness Categoriesa,b,c
METs <6
(n¼11,389)
METs 6-9
(n¼18,659)
METs 1011
(n¼23,330)
METs 12
(n¼14,172)
Overall
(N¼67,550) P
Demographic characteristics
Age (y), mean  SD 6412 5812 5211 4610 5413 <.001
Female sex, no. (%) 6757 (59) 10,696 (57) 10,718 (46) 2898 (20) 31,089 (46) <.001
Race/ethnicity, no. (%) <.001
White 6387 (56) 11,252 (60) 15,288 (66) 10,347 (73) 43,274 (64)
Black 4650 (40) 6361 (34) 6223 (27) 2569 (18) 19,713 (29)
Other 442 (4) 1046 (6) 1819 (8) 1256 (9) 4656 (7)
Comorbid conditions, no. (%)
Hypertension 9854 (87) 14,091 (76) 13,977 (60) 6239 (44) 44,161 (65) <.001
Atrial fibrillation 808 (7) 662 (3) 512 (2) 226 (2) 2208 (3) <.001
Atrial flutter 39 (0.3) 27 (0.1) 16 (0.1) 8 (0.1) 90 (0.1) <.001
Diabetes mellitus 3759 (33) 4617 (25) 3655 (16) 1091 (8) 13,122 (19) <.001
Hyperlipidemia 4982 (44) 9065 (49) 10,477 (45) 5449 (38) 29,973 (44) <.001
Obesity 2512 (22) 5725 (31) 5482 (24) 1377 (10) 15,096 (22) <.001
Sedentary lifestyle 3853 (34) 7393 (40) 8369 (36) 3497 (25) 23,112 (34) <.001
Family history of coronary artery disease 4800 (42) 9301 (50) 12,377 (53) 7462 (53) 33,940 (50) <.001
History of coronary artery disease 3548 (31) 3099 (17) 2138 (9) 802 (6) 9587 (14) <.001
History of smoking 4457 (39) 8117 (44) 10,075 (43) 5377 (38) 28,026 (41) <.001
Body mass index (kg/m2), mean  SD 31.27.2 30.16.4 29.05.2 26.94.1 29.45.9 <.001
Laboratory measurements
Low-density lipoprotein cholesterol (mg/dL),
mean  SD
12540 12538 12637 12836 12638 <.001
Very low-density lipoprotein cholesterol (mg/
dL), mean  SD
3015 3015 2916 2815 2915 <.001
High-density lipoprotein cholesterol (mg/dL),
mean  SD
4916 5116 5016 4915 5015 <.001
Total cholesterol (mg/dL), mean  SD 20246 20544 20742 20540 20543 <.001
Hemoglobin A1c (%), mean  SD 7.51.9 7.21.8 6.81.7 6.41.4 7.01.8 <.001
Medication use, no. (%)
b-Blockers 3677 (32) 5001 (27) 4415 (19) 1627 (11) 14,720 (22) <.001
Angiotensin-converting enzyme inhibitors 3389 (30) 4416 (24) 3698 (16) 1304 (9) 12,807 (19) <.001
Angiotensin receptor blockers 401 (4) 711 (4) 597 (3) 166 (1) 1875 (3) <.001
Calcium channel blockers 2688 (24) 3214 (17) 2572 (11) 807 (6) 9281 (14) <.001
Diabetes medications 1580 (14) 2230 (12) 1607 (7) 377 (3) 5794 (9) <.001
Antidepressants 832 (7) 1588 (9) 1865 (8) 711 (5) 4996 (7) <.001
Statins 2718 (24) 4820 (26) 4624 (20) 1834 (13) 13,996 (21) <.001
Aspirin 3516 (31) 4743 (25) 4516 (19) 2042 (14) 14,817 (22) <.001
Warfarin 431 (4) 276 (1) 171 (1) 59 (0.4) 937 (1) <.001
Lung disease medications 1320 (12) 1853 (10) 1896 (8) 811 (6) 5880 (9) <.001
aMET ¼ metabolic equivalent of task.
bContinuous variables are expressed as mean  SD, and categorical variables, as count (percentage). Differences were tested using analysis of variance or median test for
continuous variables and c2 test for categorical variables.
cSI conversion factors: To convert cholesterol values to mmol/L, multiply by 0.0259.
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Statistical Analyses
Baseline characteristics were categorized by
METs (<6, 6-9, 10-11, and 12) and differ-
ences were tested using c2 test for categori-
cal variables and analysis of variance for
continuous variables.
Incidence rates of overall stroke and
stroke types were calculated as number of
events per 1000 person-years for each MET
group. Unadjusted Kaplan-Meier curves
were constructed using time-to-stroke data
with log-rank testing for significant
differences.
Multivariable-adjusted Cox proportional
hazard models were used to study the associ-
ation of CRF with stroke after confirming
the proportionality assumption using log-
log plots. In continuous analyses, hazard ra-
tios (HRs) were calculated per 1-unit higher
MET. In categorical analyses, HRs were
calculated for each MET category using
METs less than 6 as the reference group,
and P value for linear trend was calculated.
Hazard ratios (95% CI) were also visualized
using bar graphs.
Adjustment variables were selected a pri-
ori based on a search of the literature.
Models were adjusted for age, sex, race/
ethnicity, hypertension, diabetes mellitus,
personal history of CAD, family history of
CAD, hyperlipidemia, cigarette smoking,
history of obesity, sedentary behavior, his-
tory of AF, medication use (b-blocker,
angiotensin-converting enzyme inhibitor,
angiotensin receptor blocker, calcium chan-
nel blocker, statin, insulin, oral hypoglyce-
mics, lung disease medication, and
antidepressant), reason for stress test,
adequate test (defined as achieving 85%
maximal predicted heart rate), incident
CAD, incident AF, incident hypertension,
and incident diabetes mellitus (all occurring
before the development of stroke and coded
as binary).
We assessed for interaction of METs with
age, sex, race/ethnicity, history of hyperten-
sion, diabetes mellitus, and hyperlipidemia.
We also stratified results by warfarin use,
history of CAD, history of CHF, or incident
AF outcomes.
A 2-sided P<.05 was considered statisti-
cally significant. All analyses were performed
using Stata/IC, version 13 (StataCorp).
RESULTS
Baseline Characteristics
Our study cohort consisted of 67,550 indi-
viduals without history of stroke with a
mean  SD age of 5413 years, 46%
(n¼31,089) women, 64% (n¼43,274) white,
and 29% (n¼19,713) black (Table 1). The
distribution of MET categories was as fol-
lows: 17% with METs <6, 28% METs 6-9,
35% METs 10-11, and 21% METs 12.
Compared with patients who achieved
METs less than 6 on treadmill stress testing,
those with METs of 12 or more were on
average younger and more likely to be male
and white but less likely to have hyperten-
sion, AF, diabetes mellitus, hyperlipidemia,
or smoking (all P<.05).
Incidence Rates
During a median follow-up of 5.4 (2.7-8.5)
years, there were 7512 overall stroke out-
comes, including 6320 ischemic strokes,
2481 hemorrhagic strokes, and 275 SAHs.
There was a stepwise lower incidence and
cumulative survival of overall stroke,
ischemic stroke, hemorrhagic stroke, and
SAH with higher MET categories (all
P<.05; Table 2; Figure 1).
Multivariable Analyses
In multivariable analyses (model 2), there
was significantly lower risk for stroke with
higher METs. For example, compared with
METs less than 6, the effect estimates for
those with METs of 12 or more were 0.42
(95% CI, 0.36-0.49) for overall stroke, 0.69
(95% CI, 0.58-0.82) for ischemic stroke,
and 0.71 (95% CI, 0.52-0.95) for hemorrhag-
ic stroke (Table 3; Figure 2). Effect estimates
for METs 6 to 9 and 10 to 11 were only sig-
nificant for overall stroke but not stroke
types. Each 1-unit higher MET on treadmill
stress testing was significantly associated
with lower risk for overall stroke (HR,
0.91; 95% CI, 0.89-0.92). Estimates were
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similar for ischemic (HR, 0.97; 95% CI, 0.95-
0.99) and hemorrhagic stroke (HR, 0.97;
95% CI, 0.95-1.00), but only significant for
the former. Results for SAH were not signif-
icant in all analyses.
Interaction Analyses
1. Age, Sex, and Race/Ethnicity With
METs. There was a graded lower risk for
overall stroke with higher METs for all age
groups, though effect estimates were stron-
ger in those younger than 40 years. Simi-
larly, there was a graded lower risk for
overall stroke for both men and women,
with effect estimates slightly stronger among
men. Both whites and blacks had a stepwise
lower risk for overall stroke, but estimates
were not significant in other race/ethnic
groups. In analyses of stroke type, there
was significantly lower risk for ischemic
stroke only for those with METs of 12 or
more who were older than 60 years, men,
white or black (Supplemental Tables 2 and
3, available online at http://www.
mayoclinicproceedings.org). Results for
hemorrhagic stroke and SAH were both not
significant.
2. Hypertension, Diabetes Mellitus, and
History of AF With METs. There was an in-
cremental lower risk for overall stroke with
higher METs regardless of hypertension or
diabetes mellitus status. Results for ischemic
stroke were significant among those with
METs of 12 or more who did not have hy-
pertension or diabetes mellitus. Results for
hemorrhagic stroke were only significant
among those with METs of 12 or more and
without hypertension. Results for SAH
were not significant. We further adjusted
for systolic and diastolic blood pressures at
peak exercise and HRs remained nonsignifi-
cant among patients with baseline diabetes
mellitus or hypertension. METs of 12 or
more remained significantly associated with
lower risk for overall stroke regardless of his-
tory of AF but only significantly associated
with ischemic or hemorrhagic stroke among
those without history (Supplemental
Table 4, available online at http://www.
mayoclinicproceedings.org).
Sensitivity Analyses
In stratified analyses, METs of 12 or more
were significantly associated with lower
risk for overall stroke regardless of warfarin
use, history of CAD, or incident AF, but re-
sults were not significant among individuals
with a history of CHF. METs of 12 or more
were not significantly associated with either
ischemic or hemorrhagic stroke among indi-
viduals using warfarin, with a history of
CHF, or those who developed incident AF
(Supplemental Table 5, available online at
http://www.mayoclinicproceedings.org).
DISCUSSION
We found that higher CRF, in particular
METs of 12 or more, was associated with
lower risk for overall stroke, including
ischemic and hemorrhagic stroke. There
was no association between CRF and SAH.
TABLE 2. Incidence Rates of Incident Stroke by Cardiorespiratory Fitness
Categories
No. of Events Incidence Rate (per 1000 person-y)
Overall stroke
METs <6 2705 41.9
METs 6-9 2377 22.0
METs 10-11 1767 12.5
METs 12 663 6.7
P d <.001
Ischemic stroke
METs <6 2343 36.0
METs 6-9 2014 18.5
METs 10-11 1440 10.1
METs 12 523 5.3
P d <.001
Hemorrhagic stroke
METs <6 961 14.1
METs 6-9 763 6.8
METs 10-11 533 3.7
METs 12 224 2.2
P d <.001
Subarachnoid hemorrhage
METs <6 97 1.4
METs 6-9 84 0.7
METs 10-11 64 0.4
METs 12 30 0.3
P d <.001
MET ¼ metabolic equivalent of task.
MAYO CLINIC PROCEEDINGS
1384 Mayo Clin Proc. n July 2020;95(7):1379-1389 n https://doi.org/10.1016/j.mayocp.2019.11.027
www.mayoclinicproceedings.org
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 13, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
Strengths of our study include a diverse sam-
ple of high-risk men and women of different
race/ethnicities with long-term follow-up for
stroke types.
Because exercise may be the only modifi-
able factor that can affect CRF,23 engaging in
at least 30 minutes or more on most days of
the week of moderate to vigorous physical
activity may lower risk for stroke.2,24,25 Prior
studies have established that higher CRF is
associated with lower cardiovascular risk
factor burden,26 which may possibly mediate
the association of CRF with incident cardio-
vascular disease.27
In the present study, we have demon-
strated an inverse association between
continuous METs and risk for stroke, which
suggests that higher METs may be beneficial
for stroke reduction. Men with METs of 12
or more had significantly lower risk for
ischemic stroke (HR, 0.64; 95% CI, 0.51-
0.80), but effect estimates in women were
not significant (HR, 0.80; 95% CI, 0.59-
1.07). Although the statistical interaction
term was borderline significant (P¼.049), it
is unlikely that there are biological differ-
ences explaining this sex discrepancy. We
therefore expect both men and women to
derive benefit from improved CRF (particu-
larly METs 12) for ischemic stroke
reduction.
The statistically significant results among
blacks and whites are likely the result of
sample size because analyses in other race/
ethnicities were underpowered. Similar to
sex differences, there are likely no biological
differences explaining the discrepant results
by race/ethnicity.
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FIGURE 1. Unadjusted Kaplan-Meier graphs for the association of cardiorespiratory fitness and incident stroke. A, Overall stroke. B,
Ischemic stroke. C, Hemorrhagic stroke. D, Subarachnoid hemorrhage. Log-rank testing P<.001 for all stroke outcomes.
FITNESS AND RISK FOR STROKE
Mayo Clin Proc. n July 2020;95(7):1379-1389 n https://doi.org/10.1016/j.mayocp.2019.11.027
www.mayoclinicproceedings.org
1385
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 13, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
CRF was not significantly associated
with ischemic or hemorrhagic stroke among
those with hypertension or diabetes mellitus.
This could be related to competing risk for
other outcomes that were unaccounted for
that may have resulted in censoring.
Furthermore, because hypertension and dia-
betes mellitus are significant risk factors for
stroke, CRF may have less predictive value
in the presence of these factors. Importantly,
we found that CRF was inversely associated
with risk for overall stroke among patients
with a history of AF, an encouraging finding
given the high burden of stroke in this pop-
ulation. Clinicians treating patients with AF
should consider promoting physical activity
and exercise as a heart healthy lifestyle that
lowers the burden of cardiovascular risk fac-
tors and possibly risk of stroke in this high-
risk population. Results for stroke subtypes
were not significant, though this analysis
may have been underpowered. Furthermore,
there was no significant association between
CRF and SAH in our study. This is likely due
to the known association of SAH with other
risk factors such as trauma, cerebral aneu-
rysm rupture, or alcohol and drug abuse,
which are not associated with CRF.
Few studies have examined the associa-
tion between CRF and incident stroke but
these were either limited to men13,14 or did
not examine stroke types.12 In the Aerobics
Center Longitudinal Study population, Lee
and Blair14 studied 16,878 men aged 40 to
87 years who underwent a maximal tread-
mill exercise test and were followed up for
fatal strokes over a 10-year duration. Both
moderate and high levels of CRF were
inversely associated with stroke deaths. In
a study by Prestgaard et al15 of healthy
middle-aged men, those who later became
unfit had significantly higher risk for stroke.
There are important limitations to our
study. The FIT Project is based on data
from a single health system and therefore re-
sults may not be generalizable to other study
populations. There is the potential for
referral bias because most of our patients un-
derwent a clinically indicated stress; there-
fore, our findings may not be generalizable
to asymptomatic individuals who are other-
wise healthy. There may have been misclas-
sification of risk factors due to self-report
or reliance on the medical record given the
retrospective nature of our study. Inability
to exclude patients based on other nonre-
corded comorbid conditions may also have
resulted in selection bias. Exclusive use of
the Bruce protocol may have resulted in a
possible selection bias because patients who
could not undergo this testing modality
TABLE 3. Multivariable-Adjusted Hazard Ratios (95% CI) for the Association of
Cardiorespiratory Fitness and Incident Strokea
Model 1b Model 2c
Overall stroke
METs <6 1 (reference) 1 (reference)
METs 6-9 0.71 (0.65-0.77) 0.73 (0.67-0.80)
METs 10-11 0.55 (0.49-0.61) 0.58 (0.52-0.65)
METs 12 0.38 (0.33-0.44) 0.42 (0.36-0.49)
P for trendd <.001 <.001
1-unit METs 0.90 (0.89-0.91) 0.91 (0.89-0.92)
Ischemic stroke
METs <6 1 (reference) 1 (reference)
METs 6-9 0.72 (0.66-0.80) 1.00 (0.90-1.10)
METs 10-11 0.55 (0.49-0.61) 0.91 (0.81-1.03)
METs 12 0.38 (0.32-0.45) 0.69 (0.58-0.82)
P for trendd <.001 <.001
1-unit higher METs 0.90 (0.89-0.91) 0.97 (0.95-0.99)
Hemorrhagic stroke
METs <6 1 (reference) 1 (reference)
METs 6-9 0.64 (0.54-0.75) 1.03 (0.87-1.24)
METs 10-11 0.44 (0.37-0.54) 0.93 (0.75-1.14)
METs 12 0.32 (0.24-0.42) 0.71 (0.52-0.95)
P for trendd <.001 .05
1-unit higher METs 0.88 (0.86-0.90) 0.97 (0.95-1.00)
Subarachnoid hemorrhage
METs <6 1 (reference) 1 (reference)
METs 6-9 0.85 (0.51-1.41) 0.98 (0.48-2.03)
METs 10-11 0.71 (0.40-1.27) 0.64 (0.28-1.46)
METs 12 0.52 (0.23-1.19) 0.88 (0.28-2.77)
P for trendd .11 .49
1-unit higher METs 0.94 (0.87-1.02) 1.97 (0.86-1.10)
aMET ¼ metabolic equivalent of task.
bModel 1 is adjusted for demographics (age, sex, and race) plus comorbid conditions (hyper-
tension, diabetes mellitus, personal history of coronary artery disease, family history of coronary
artery disease, hyperlipidemia, cigarette smoking, obesity, sedentary behavior, atrial fibrillation, and
atrial flutter) and medication use (b-blockers, angiotensin-converting enzyme inhibitors, angio-
tensin receptor blockers, calcium channel blockers, statins, insulin, oral hypoglycemics, lung disease
medications, and antidepressants).
cModel 2 is adjusted for model 1 covariates plus stress test variables (reason for stress test and
adequate test), incident disease outcomes (coronary artery disease, atrial fibrillation, hypertension,
and diabetes mellitus).
dP value represents the linear trend of hazard ratio across MET categories.
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due to age, obesity, frailty, or physical limita-
tions were likely tested using different
methods and therefore excluded from our
study. CRF may have been overestimated
in some individuals who held on to the
railing for support during the stress test
especially given that metabolic testing for
CRF (eg, VO2max) was not performed in
our study. CRF was only assessed using
METs so alternative methods of estimating
or measuring CRF such as the Duke Activity
Index Status or VO2max testing could not be
used to verify our findings. To limit bias
associated with loss to follow-up outside
the health system, patients were censored
when ongoing coverage with the health
plan could no longer be confirmed, which
may have resulted in a conservative bias.
Although we used validated ICD-9 codes to
ascertain incident stroke, stroke outcomes
in our study were not adjudicated by an in-
dependent panel of clinical experts, which
may have resulted in misclassification.
Furthermore, no prior study has examined
the specificity and sensitivity of these codes
in the FIT cohort. In addition, we do not
have information for stroke-related mortality
so fatal stroke outcomes could not be exam-
ined. We did not have data for the number of
participants who had recurrent stroke out-
comes. We were also not able to determine
whether patients had concurrent stroke diag-
noses; for example, an ischemic stroke with
hemorrhagic conversion. Patients and physi-
cians were unblinded to the fitness results
and therefore use of preventive medications
such as lipid level and blood pressure
lowering may have been intensified during
follow-up, which could have biased some re-
sults to the null. We only assessed CRF at
baseline, but change in fitness levels over
time is also important to evaluate. Although
we attempted to adjust for known risk fac-
tors for stroke, information on other factors
that affect CRF such as genetics was not
available and therefore we cannot exclude
the possibility of residual confounding. The
FIT Project has higher rates of stroke
compared with other cohorts, possibly
related to uncontrolled hypertension in
blacks28 resulting in higher incidence of
stroke in this race/ethnicity (16% in blacks
vs 10% in whites in our study). This could
also be related to secular changes during
the follow-up period (1991-2009) in referral
patterns or treatment; for example, the use of
warfarin for AF anticoagulation in the 1990s
was infrequent (1.2% in the FIT Project).
CONCLUSION
In conclusion, we found that higher CRF is
associated with lower risk for overall stroke,
including ischemic and hemorrhagic stroke.
Further studies are required to demonstrate
whether improvement in CRF over time is
associated with lower risk for future stroke.
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FIGURE 2. Bar graph with multivariable adjusted hazard ratios for the as-
sociation of cardiorespiratory fitness and incident stroke. Model is adjusted
for age, sex, race, history of hypertension, history of diabetes mellitus,
personal history of coronary artery disease (CAD), family history of CAD,
history of hyperlipidemia, history of cigarette smoking, history of obesity,
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take responsibility for the accuracy of all
data.
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ICD-9 = International Classification of Diseases, Ninth Revi-
sion; MET = metabolic equivalent of task; SAH = sub-
arachnoid hemorrhage; VO2max = maximal oxygen uptake
Affiliations (Continued from the first page of this
article.): sachusetts Medical School, Worcester (W.Q.);
Section of Cardiovascular Research, Department of Medi-
cine, Baylor College of Medicine (S.S.V.); Health Policy,
Quality & Informatics Program, Michael E. DeBakey Veter-
ans Affairs Medical Center Health Services Research and
Development Center for Innovations (S.S.V.); Section of
Cardiology, Michael E. DeBakey Veterans Affairs Medical
Center, Houston, TX (S.S.V.); Division of Cardiovascular
Medicine, Henry Ford Hospital, Detroit, MI (C.A.B., J.K.E.,
S.J.K.); and Department of Cardiac Imaging, Houston Meth-
odist DeBakey Heart & Vascular Center, TX (M.H.A.-M.).
Potential Competing Interests: The authors report no
competing interests.
Data Previously Presented: This work was presented on
March 16, 2019 at the American College of Cardiology
68th Scientific Sessions in New Orleans, LA.
Correspondence: Address to Mouaz H. Al-Mallah, MD,
MSc, Houston Methodist DeBakey Heart & Vascular Center,
Houston Methodist Hospital, 6565 Fannin St, Smith-19,
Houston, TX 77030 (mouaz74@gmail.com; Twitter:
@almallahmo).
REFERENCES
1. Benjamin EJ, Virani SS, Callaway CW, et al; American Heart
Association Council on Epidemiology and Prevention Statis-
tics Committee and Stroke Statistics Subcommittee. Heart
disease and stroke statistics-2018 update: a report from
the American Heart Association. Circulation. 2018;137(12):
e67-e492.
2. O’Donnell MJ, Chin SL, Rangarajan S, et al; INTERSTROKE in-
vestigators. Global and regional effects of potentially modifiable
risk factors associated with acute stroke in 32 countries
(INTERSTROKE): a case-control study. Lancet. 2016;
388(10046):761-775.
3. Blair SN, Kohl HW, Paffenbarger RS, Clark DG, Cooper KH,
Gibbons LW. Physical fitness and all-cause mortality. A pro-
spective study of healthy men and women. JAMA. 1989;
262(17):2395-2401. http://www.ncbi.nlm.nih.gov/pubmed/
2795824. Accessed April 29, 2018.
4. Al-Mallah MH, Qureshi WT, Keteyian SJ, et al. Racial differences
in the prognostic value of cardiorespiratory fitness (results from
the Henry Ford Exercise Testing Project). Am J Cardiol. 2016;
117(9):1449-1454.
5. Ehrman JK, Brawner CA, Al-Mallah MH, Qureshi WT, Blaha MJ,
Keteyian SJ. Cardiorespiratory fitness change and mortality risk
among black and white patients: Henry Ford Exercise Testing
(FIT) Project. Am J Med. 2017;130(10):1177-1183.
6. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and
nomographic assessment of functional aerobic impairment in
cardiovascular disease. Am Heart J. 1973;85(4):546-562. http://
www.ncbi.nlm.nih.gov/pubmed/4632004. Accessed April 29,
2018.
7. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a
quantitative predictor of all-cause mortality and cardiovascular
events in healthy men and women. JAMA. 2009;301(19):
2024-2035.
8. Lee D-C, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN.
Changes in fitness and fatness on the development of cardio-
vascular disease risk factors hypertension, metabolic syn-
drome, and hypercholesterolemia. J Am Coll Cardiol. 2012;
59(7):665-672.
9. Juraschek SP, Blaha MJ, Blumenthal RS, et al. Cardiorespiratory
fitness and incident diabetes: the FIT (Henry Ford ExercIse
Testing) Project. Diabetes Care. 2015;38(6):1075-1081.
10. Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory
fitness and risk of incident atrial fibrillation: results from the
Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;
131(21):1827-1834.
11. Hung RK, Al-Mallah MH, McEvoy JW, et al. Prognostic value of
exercise capacity in patients with coronary artery disease: the
FIT (Henry Ford ExercIse Testing) project. Mayo Clin Proc.
2014;89(12):1644-1654.
12. Hooker SP, Sui X, Colabianchi N, et al. Cardiorespiratory
fitness as a predictor of fatal and nonfatal stroke in asymptom-
atic women and men. Stroke. 2008;39(11):2950-2957.
13. Kurl S, Laukkanen JA, Rauramaa R, Lakka TA, Sivenius J,
Salonen JT. Cardiorespiratory fitness and the risk for stroke in
men. Arch Intern Med. 2003;163(14):1682-1688.
14. Lee CD, Blair SN. Cardiorespiratory fitness and stroke mortality
in men. Med Sci Sports Exerc. 2002;34(4):592-595.
15. Prestgaard E, Mariampillai J, Engeseth K, et al. Change in cardio-
respiratory fitness and risk of stroke and death [published on-
line ahead of print Dcember 10, 2018]. Stroke. https://doi.org/
10.1161/STROKEAHA.118.021798.
16. Pandey A, Patel MR, Willis B, et al. Association between midlife
cardiorespiratory fitness and risk of stroke: the Cooper Center
Longitudinal Study. Stroke. 2016;47(7):1720-1726.
17. Al-Mallah MH, Keteyian SJ, Brawner CA, Whelton S,
Blaha MJ. Rationale and design of the Henry Ford Exercise
Testing Project (the FIT Project). Clin Cardiol. 2014;37(8):
456-461.
18. Rifai MA, Qureshi WT, Dardari Z, et al. The interplay of the
global atherosclerotic cardiovascular disease risk scoring and
cardiorespiratory fitness for the prediction of all-cause mor-
tality and myocardial infarction: the Henry Ford ExercIse
Testing Project (The FIT Project). Am J Cardiol. 2019;
124(4):511-517.
19. Gibbons RJ, Balady GJ, Bricker JT, et al; American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. Committee to Update the 1997 Exercise Testing
Guidelines. ACC/AHA 2002 guideline update for exercise
testing: summary article. A report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee to Update the 1997 Exercise Testing
Guidelines). J Am Coll Cardiol. 2002;40(8):1531-1540. http://
www.ncbi.nlm.nih.gov/pubmed/12392846. Accessed April 29,
2018.
20. Shaya GE, Al-Mallah MH, Hung RK, et al. High exercise capacity
attenuates the risk of early mortality after a first myocardial
infarction: the Henry Ford Exercise Testing (FIT) Project.
Mayo Clin Proc. 2016;91(2):129-139.
21. Jones SA, Gottesman RF, Shahar E, Wruck L, Rosamond WD.
Validity of hospital discharge diagnosis codes for stroke: the
Atherosclerosis Risk in Communities Study. Stroke. 2014;
45(11):3219-3225.
22. Aladin AI, Al Rifai M, Rasool SH, et al. The association of
resting heart rate and incident hypertension: the Henry
MAYO CLINIC PROCEEDINGS
1388 Mayo Clin Proc. n July 2020;95(7):1379-1389 n https://doi.org/10.1016/j.mayocp.2019.11.027
www.mayoclinicproceedings.org
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 13, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
Ford Hospital Exercise Testing (FIT) Project. Am J Hypertens.
2016;29(2):251-257.
23. Kemi OJ, Wisloff U. High-intensity aerobic exercise training im-
proves the heart in health and disease. J Cardiopulm Rehabil Prev.
2010;30(1):2-11.
24. Eckel RH, Jakicic JM, Ard JD, et al. American College of Cardi-
ology/American Heart Association Task Force on Practice
Guidelines. 2013 AHA/ACC guideline on lifestyle management
to reduce cardiovascular risk: a report of the American College
of Cardiology/American Heart Association Task Force on Prac-
tice Guidelines. Circulation. 2014;129(25 suppl 2):S76-S99.
25. Meschia JF, Bushnell C, Boden-Albala B, et al; American Heart
Association Stroke Council; Council on Cardiovascular and
Stroke Nursing; Council on Clinical Cardiology; Council on
Functional Genomics and Translational Biology; Council on
Hypertension. Guidelines for the primary prevention of stroke:
a statement for healthcare professionals from the American
Heart Association/American Stroke Association. Stroke. 2014;
45(12):3754-3832.
26. LaMonte MJ, Eisenman PA, Adams TD, Shultz BB,
Ainsworth BE, Yanowitz FG. Cardiorespiratory fitness and cor-
onary heart disease risk factors: the LDS Hospital Fitness Insti-
tute cohort. Circulation. 2000;102(14):1623-1628.
27. Erez A, Kivity S, Berkovitch A, et al. The association between
cardiorespiratory fitness and cardiovascular risk may be modu-
lated by known cardiovascular risk factors. Am Heart J. 2015;
169(6):916-923.e1.
28. Ferdinand KC, Armani AM. The management of hyperten-
sion in African Americans. Crit Pathw Cardiol. 2007;6(2):
67-71.
FITNESS AND RISK FOR STROKE
Mayo Clin Proc. n July 2020;95(7):1379-1389 n https://doi.org/10.1016/j.mayocp.2019.11.027
www.mayoclinicproceedings.org
1389
Downloaded for Anonymous User (n/a) at Henry Ford Hospital / Henry Ford Health System (CS North America) from ClinicalKey.com by Elsevier on August 13, 2020.
For personal use only. No other uses without permission. Copyright ©2020. Elsevier Inc. All rights reserved.
